Skip to main content
NewslettersWatchlist
Introducing The Globe and Mail Trade Off — A Free Stock-Picking Contest With $10,000 in Cash Prizes. Enter Now!

Oncolytics Bio(ONC-T)
TSX

Today's Change
Real-Time Last Update

Oncolytics Bio

322 11th Avenue S.W
Suite 804
Calgary AB T2R 0C5 CAN
P: 403-670-7377
F: 403-283-0858
https://www.oncolyticsbiotech.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

    Key Executives

    NameTitle
    Wayne PisanoCEO/Chairman of the Board/Director
    Kirk J. LookCFO
    Allison HagermanVice President, Divisional
    Thomas C. HeinemanChief Medical Officer
    Amy G. LevinVice President, Divisional
    Christophe DegoisVice President, Divisional

    More from The Globe

    Insider Report: Director invests $13-million in a stock trading near oversold levels
    The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.
    Bullish on Saputo Inc.
    Monica Rizk
    opinion
    After failing to find a buyer, H&R REIT seems intent on ignoring a proven game plan
    Andrew Willis
    number cruncher
    How the valuations of TSX utility stocks stack up
    Brian Donovan
    U.S. utilities offer diversification and cash flow. Here are two I recommend
    Gordon Pape
    The most oversold and overbought stocks on the TSX
    The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.
    Stocks close sharply lower as U.S. indexes break below key technical support level
    File #: 9658851 Market analysis Market Analyze on lcd screen pen pointing at a business graph shallow depth of field Credit: iStockphoto (Royalty-Free) Keywords: Trading, Risk, Stock Market Data, Stock Market, Technology, Chart, Trading Board, Finance, Analyzing, Curve, Manager
    Dye & Durham stock sells off on disappointing preliminary results
    Office buildings in Toronto’s Financial District are photographed on along Adelaide St. West on Sept 28, 2023. (Fred Lum/The Globe and Mail)

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2025.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.